Published in PLoS One on December 31, 2012
Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol (2003) 15.65
Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur J Immunol (1993) 3.73
The birnavirus crystal structure reveals structural relationships among icosahedral viruses. Cell (2005) 2.44
Papillomavirus-like particles induce acute activation of dendritic cells. J Immunol (2001) 2.28
How will HPV vaccines affect cervical cancer? Nat Rev Cancer (2006) 2.23
Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides. J Immunol (1995) 2.05
The coming of age of virus-like particle vaccines. Biol Chem (2008) 1.85
Adjuvants for cancer vaccines. Semin Immunol (2010) 1.48
IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase. J Immunol (2001) 1.46
Strategies for cancer vaccine development. J Biomed Biotechnol (2010) 1.26
Virus-like particles as a vaccine delivery system: myths and facts. Hum Vaccin (2008) 1.22
The 2.6-Angstrom structure of infectious bursal disease virus-derived T=1 particles reveals new stabilizing elements of the virus capsid. J Virol (2006) 1.10
A combination of DNA vaccines targeting human papillomavirus type 16 E6 and E7 generates potent antitumor effects. Gene Ther (2006) 1.08
DNA vaccines for cervical cancer: from bench to bedside. Exp Mol Med (2007) 1.02
The functioning antigens: beyond just as the immunological targets. Cancer Sci (2009) 1.01
Cross-presentation of epitopes on virus-like particles via the MHC I receptor recycling pathway. Immunol Cell Biol (2011) 0.98
Molecular epidemiology of human papillomavirus. J Formos Med Assoc (2008) 0.97
The combination of GM-CSF and IL-2 as local adjuvant shows synergy in enhancing peptide vaccines and provides long term tumor protection. Vaccine (2007) 0.92
The capsid protein of infectious bursal disease virus contains a functional alpha 4 beta 1 integrin ligand motif. Virology (2009) 0.90
Lymph node-targeted immunotherapy mediates potent immunity resulting in regression of isolated or metastatic human papillomavirus-transformed tumors. Clin Cancer Res (2009) 0.88
Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway. Virology (1998) 0.88
Rejection of large HPV-16 expressing tumors in aged mice by a single immunization of VacciMax encapsulated CTL/T helper peptides. J Transl Med (2007) 0.87
Tumor immunogenicity and responsiveness to cancer vaccine therapy: the state of the art. Semin Immunol (2010) 0.87
Therapeutic vaccines against human papillomavirus and cervical cancer. Open Virol J (2009) 0.85
Epitope mapping of capsid proteins VP2 and VP3 of infectious bursal disease virus. Arch Virol (1996) 0.85
Modulation of macrophages by infectious bursal disease virus. Cytogenet Genome Res (2007) 0.83
Cancer immunotherapy and nanomedicine. Pharm Res (2010) 0.83
The efficacy of a DNA vaccine containing inserted and replicated regions of the E7 gene for treatment of HPV-16 induced tumors. Vaccine (2007) 0.82
Follicular and marginal zone B cells fail to cross-present MHC class I-restricted epitopes derived from viral particles. J Immunol (2009) 0.81
Reducing patient risk for human papillomavirus infection and cervical cancer. J Am Osteopath Assoc (2008) 0.81
Long-term protection against human papillomavirus e7-positive tumor by a single vaccination of adeno-associated virus vectors encoding a fusion protein of inactivated e7 of human papillomavirus 16/18 and heat shock protein 70. Hum Gene Ther (2010) 0.80
Synthesis of multiple antigenic peptides (MAPs)-strategies and limitations. J Pept Sci (2010) 0.79
Hepatitis B surface antigen fusions delivered by DNA vaccination elicit CTL responses to human papillomavirus oncoproteins associated with tumor protection. Cancer Gene Ther (2010) 0.78
A DNA vaccine constructed with human papillomavirus type 16 (HPV16) E7 and E6 genes induced specific immune responses. Gynecol Oncol (2006) 0.78
Antigenic and immunogenic properties of baculovirus-expressed infectious bursal disease viral proteins. Avian Dis (1998) 0.76
Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity (2007) 4.65
Virus factories: associations of cell organelles for viral replication and morphogenesis. Biol Cell (2005) 2.65
Telomere-binding protein TRF2 binds to and stimulates the Werner and Bloom syndrome helicases. J Biol Chem (2002) 2.53
AMP-activated kinase regulates cytoplasmic HuR. Mol Cell Biol (2002) 2.14
Characterization of a common precursor population for dendritic cells. Nature (2002) 1.88
Defective RNA replication and late gene expression in temperature-sensitive influenza viruses expressing deleted forms of the NS1 protein. J Virol (2004) 1.88
The cost of resistance to colistin in Acinetobacter baumannii: a proteomic perspective. Proteomics (2009) 1.83
Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer. Proc Natl Acad Sci U S A (2006) 1.70
Characterization of a new subpopulation of mouse CD8alpha+ B220+ dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential. Blood (2002) 1.70
Differentiation and function of mouse monocyte-derived dendritic cells in steady state and inflammation. Immunol Rev (2010) 1.68
In vivo induction of immune responses to pathogens by conventional dendritic cells. Immunity (2008) 1.60
Repositioning of dexamethasone intravitreal implant (Ozurdex) migrated into the anterior chamber. Int Ophthalmol (2012) 1.59
Physical and functional mapping of the replication protein a interaction domain of the werner and bloom syndrome helicases. J Biol Chem (2005) 1.52
Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes. Europace (2010) 1.50
The clinical characteristics of Werner syndrome: molecular and biochemical diagnosis. Hum Genet (2008) 1.48
Dendritic cell differentiation potential of mouse monocytes: monocytes represent immediate precursors of CD8- and CD8+ splenic dendritic cells. Blood (2003) 1.48
IL-4 blocks TH1-polarizing/inflammatory cytokine gene expression during monocyte-derived dendritic cell differentiation through histone hypoacetylation. J Allergy Clin Immunol (2013) 1.39
Werner syndrome and the function of the Werner protein; what they can teach us about the molecular aging process. Carcinogenesis (2003) 1.37
Linkage between Werner syndrome protein and the Mre11 complex via Nbs1. J Biol Chem (2004) 1.36
Monocyte-derived dendritic cells in innate and adaptive immunity. Immunol Cell Biol (2008) 1.35
Cooperation of the Cockayne syndrome group B protein and poly(ADP-ribose) polymerase 1 in the response to oxidative stress. Mol Cell Biol (2005) 1.31
Interferon-β production via Dectin-1-Syk-IRF5 signaling in dendritic cells is crucial for immunity to C. albicans. Immunity (2013) 1.27
Escherichia coli cell surface perturbation and disruption induced by antimicrobial peptides BP100 and pepR. J Biol Chem (2010) 1.27
Monocyte-derived dendritic cells. Semin Immunol (2005) 1.27
WRN interacts physically and functionally with the recombination mediator protein RAD52. J Biol Chem (2003) 1.27
Werner syndrome protein phosphorylation by abl tyrosine kinase regulates its activity and distribution. Mol Cell Biol (2003) 1.23
Statins induce regulatory T cell recruitment via a CCL1 dependent pathway. J Immunol (2008) 1.22
Monocyte migration to inflamed skin and lymph nodes is differentially controlled by L-selectin and PSGL-1. Blood (2008) 1.21
Neutralization of human respiratory syncytial virus infectivity by antibodies and low-molecular-weight compounds targeted against the fusion glycoprotein. J Virol (2010) 1.21
The Werner syndrome protein stimulates DNA polymerase beta strand displacement synthesis via its helicase activity. J Biol Chem (2003) 1.19
CCL2 shapes macrophage polarization by GM-CSF and M-CSF: identification of CCL2/CCR2-dependent gene expression profile. J Immunol (2014) 1.18
Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations. J Antimicrob Chemother (2005) 1.16
Werner protein stimulates topoisomerase I DNA relaxation activity. Cancer Res (2003) 1.15
Connecting peptide physicochemical and antimicrobial properties by a rational prediction model. PLoS One (2011) 1.11
CD8alpha+ dendritic cells originate from the CD8alpha- dendritic cell subset by a maturation process involving CD8alpha, DEC-205, and CD24 up-regulation. Blood (2002) 1.11
Combined endocardial and epicardial catheter ablation in arrhythmogenic right ventricular dysplasia incorporating scar dechanneling technique. Circ Arrhythm Electrophysiol (2011) 1.11
Role for the Werner syndrome protein in the promotion of tumor cell growth. Mech Ageing Dev (2007) 1.10
Dramatic increase in lymph node dendritic cell number during infection by the mouse mammary tumor virus occurs by a CD62L-dependent blood-borne DC recruitment. Blood (2002) 1.08
Werner syndrome protein directly binds to the AAA ATPase p97/VCP in an ATP-dependent fashion. J Struct Biol (2004) 1.07
Intracameral bevacizumab (Avastin) for neovascular glaucoma: a pilot study in 6 patients. J Glaucoma (2009) 1.07
Activity of cecropin A-melittin hybrid peptides against colistin-resistant clinical strains of Acinetobacter baumannii: molecular basis for the differential mechanisms of action. Antimicrob Agents Chemother (2006) 1.07
Key Golgi factors for structural and functional maturation of bunyamwera virus. J Virol (2005) 1.06
Modulation of Werner syndrome protein function by a single mutation in the conserved RecQ domain. J Biol Chem (2005) 1.05
Bactericidal and membrane disruption activities of the eosinophil cationic protein are largely retained in an N-terminal fragment. Biochem J (2009) 1.02
Transcriptional profiling of MCF7 breast cancer cells in response to 5-Fluorouracil: relationship with cell cycle changes and apoptosis, and identification of novel targets of p53. Int J Cancer (2006) 1.01
AMPA: an automated web server for prediction of protein antimicrobial regions. Bioinformatics (2011) 0.99
Three-dimensional architecture of scar and conducting channels based on high resolution ce-CMR: insights for ventricular tachycardia ablation. Circ Arrhythm Electrophysiol (2013) 0.98
Galectin-1 is a novel functional receptor for tissue plasminogen activator in pancreatic cancer. Gastroenterology (2008) 0.98
Novel replication complex architecture in rubella replicon-transfected cells. Cell Microbiol (2006) 0.98
Enhanced mucosal immunoglobulin A response and solid protection against foot-and-mouth disease virus challenge induced by a novel dendrimeric peptide. J Virol (2008) 0.97
Improving safety of epicardial ventricular tachycardia ablation using the scar dechanneling technique and the integration of anatomy, scar components, and coronary arteries into the navigation system. Circulation (2012) 0.97
Membrane-transferring sequences of the HIV-1 Gp41 ectodomain assemble into an immunogenic complex. J Mol Biol (2006) 0.97
Amphibian antimicrobial peptides and Protozoa: lessons from parasites. Biochim Biophys Acta (2008) 0.97
Selection of an antibody library identifies a pathway to induce immunity by targeting CD36 on steady-state CD8 alpha+ dendritic cells. J Immunol (2008) 0.96
Comparative analysis of transverse intrafascicular multichannel, longitudinal intrafascicular and multipolar cuff electrodes for the selective stimulation of nerve fascicles. J Neural Eng (2011) 0.96
Activities of polymyxin B and cecropin A-,melittin peptide CA(1-8)M(1-18) against a multiresistant strain of Acinetobacter baumannii. Antimicrob Agents Chemother (2002) 0.95
Immunogenicity and T cell recognition in swine of foot-and-mouth disease virus polymerase 3D. Virology (2004) 0.95
Structural analysis and assembly of the HIV-1 Gp41 amino-terminal fusion peptide and the pretransmembrane amphipathic-at-interface sequence. Biochemistry (2006) 0.93
Bcl-x(L)-mediated changes in metabolic pathways of breast cancer cells: from survival in the blood stream to organ-specific metastasis. Am J Pathol (2005) 0.93
Use of myocardial scar characterization to predict ventricular arrhythmia in cardiac resynchronization therapy. Europace (2012) 0.91
New insights into the tPA-annexin A2 interaction. Is annexin A2 CYS8 the sole requirement for this association? J Biol Chem (2002) 0.91
A proteomic approach to the identification of new tPA receptors in pancreatic cancer cells. Proteomics (2006) 0.90
Monocytes as effector cells: activated Ly-6C(high) mouse monocytes migrate to the lymph nodes through the lymph and cross-present antigens to CD8+ T cells. Eur J Immunol (2012) 0.90
Secondary structure and lipid interactions of the N-terminal segment of pulmonary surfactant SP-C in Langmuir films: IR reflection-absorption spectroscopy and surface pressure studies. Biochemistry (2002) 0.90
NMR and modeling studies of protein-carbohydrate interactions: synthesis, three-dimensional structure, and recognition properties of a minimum hevein domain with binding affinity for chitooligosaccharides. Chembiochem (2004) 0.90
Werner syndrome protein 1367 variants and disposition towards coronary artery disease in Caucasian patients. Mech Ageing Dev (2004) 0.90
The generation of antimicrobial peptide activity: a trade-off between charge and aggregation? Angew Chem Int Ed Engl (2011) 0.89
The effect of cyclization on the enzymatic degradation of herpes simplex virus glycoprotein D derived epitope peptide. J Pept Sci (2005) 0.88
Imaging of plasmacytoid dendritic cell interactions with T cells. Blood (2008) 0.88
Reduced incorporation of the influenza B virus BM2 protein in virus particles decreases infectivity. Virology (2004) 0.88
Refining the eosinophil cationic protein antibacterial pharmacophore by rational structure minimization. J Med Chem (2011) 0.87
Two human host defense ribonucleases against mycobacteria, the eosinophil cationic protein (RNase 3) and RNase 7. Antimicrob Agents Chemother (2013) 0.87
New bradykinin analogues modified in the C-terminal part with sterically restricted 1-aminocyclohexane-1-carboxylic acid. J Med Chem (2005) 0.86
A simple approach to well-defined sugar-coated surfaces for interaction studies. Chembiochem (2005) 0.86
Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma. Virus Res (2005) 0.86
Diagnosis of laryngopharyngeal reflux disease with digital imaging. Otolaryngol Head Neck Surg (2003) 0.86
Orcokinins in insects and other invertebrates. Insect Biochem Mol Biol (2004) 0.86
Identification of new leishmanicidal peptide lead structures by automated real-time monitoring of changes in intracellular ATP. Biochem J (2003) 0.86
Energetics and partition of two cecropin-melittin hybrid peptides to model membranes of different composition. Biophys J (2007) 0.86
The "CPC clip motif": a conserved structural signature for heparin-binding proteins. PLoS One (2012) 0.86
The C-terminus of H-Ras as a target for the covalent binding of reactive compounds modulating Ras-dependent pathways. PLoS One (2011) 0.86
Hepatitis C virus population analysis of a single-source nosocomial outbreak reveals an inverse correlation between viral load and quasispecies complexity. J Gen Virol (2004) 0.85
RUNX3 negatively regulates CD36 expression in myeloid cell lines. J Immunol (2006) 0.85
Therapeutic index of gramicidin S is strongly modulated by D-phenylalanine analogues at the beta-turn. J Med Chem (2009) 0.84
Ranacyclins, a new family of short cyclic antimicrobial peptides: biological function, mode of action, and parameters involved in target specificity. Biochemistry (2003) 0.84
Antimicrobial peptide action on parasites. Curr Drug Targets (2012) 0.84
Inhibition of paclitaxel-induced proteasome activation influences paclitaxel cytotoxicity in breast cancer cells in a sequence-dependent manner. Cell Cycle (2007) 0.84
Structure-activity relationship of CART (cocaine- and amphetamine-regulated transcript) peptide fragments. Peptides (2007) 0.84
Antimicrobial action and cell agglutination by the eosinophil cationic protein are modulated by the cell wall lipopolysaccharide structure. Antimicrob Agents Chemother (2012) 0.84
NMR structural determinants of eosinophil cationic protein binding to membrane and heparin mimetics. Biophys J (2010) 0.83
Model-Based Design and Experimental Validation of Control Modules for Neuromodulation Devices. IEEE Trans Biomed Eng (2015) 0.83
Molecular characterization of the interaction of crotamine-derived nucleolar targeting peptides with lipid membranes. Biochim Biophys Acta (2012) 0.83
Ribonucleases as a host-defence family: evidence of evolutionarily conserved antimicrobial activity at the N-terminus. Biochem J (2013) 0.83
A comparative study of different presentation strategies for an HIV peptide immunogen. Bioconjug Chem (2004) 0.83
Midterm 'super-response' to cardiac resynchronization therapy by biventricular pacing with fusion: insights from electro-anatomical mapping. Europace (2009) 0.83
Partial protection against classical swine fever virus elicited by dendrimeric vaccine-candidate peptides in domestic pigs. Vaccine (2011) 0.82
Interaction and lipid-induced conformation of two cecropin-melittin hybrid peptides depend on peptide and membrane composition. J Phys Chem B (2005) 0.82
Synthetic approaches to multivalent lipopeptide dendrimers containing cyclic disulfide epitopes of foot-and-mouth disease virus. Bioconjug Chem (2003) 0.82